AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2012
Sep 24, 2012
30793_dirs_2012-09-24_fdbe2600-a89e-44c7-a099-b77263850b98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-09-21
Reporting Person: Hurd Donald R (SVP, Chief Commerical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-21 | Common Stock | P | 15000 | $1.99 | Acquired | 15000 | Direct |
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Board/Management Information
2026
Jan 5